January 27, 2021
LA JOLLA—A collaborative team of Salk scientists led by Professor 约翰·雷诺兹 will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine aging across the life span, including age-related neurodegenerative diseases such as Alzheimer’s disease. The research will advance our understanding of aging mechanisms at the cognitive, genomic and cellular levels with potentially direct translatability to humans. Other members of the team include Salk President and Professor 鲁斯蒂·盖奇, Staff Scientist 尤里·马诺尔, Senior Staff Researcher Courtney Glavis-Bloom, and Carol Marchetto, an assistant professor at the University of California San Diego.
“Aging is the greatest risk factor for neurodegenerative diseases, yet we know very little about how the brain ages across the life span,” says Gage. “With this generous new funding from the Larry L. Hillblom Foundation, we will be able to explore this scientific mystery and hope to uncover some of the basic mechanisms of brain aging.”
For this newly funded project, the Salk team will examine the link between metabolism of the aging brain and cognitive decline. Neurons use nearly ten times the amount of energy as any other cell type, making them especially susceptible to metabolic dysfunction. The main energy source for neurons are the cells’ powerhouses, the mitochondria, which experience significant deterioration as the brain ages. The scientists will test whether mitochondrial impairment is driving the cognitive decline observed in neurodegenerative diseases.
“We think age-related mitochondrial deterioration could be driving the cognitive decline observed in many neurodegenerative diseases,” says Reynolds. “We are extremely grateful to the Larry L. Hillblom Foundation for funding our project, so that we can examine this theory in extraordinary detail.”
The Larry L. Hillblom Foundation supports medical research within the state of California and facilitates interaction between networks of researchers.
宣传办公室
电话:(858) 453-4100
press@salk.edu
萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.